Literature DB >> 32936044

Creating a Colocation Unit for End-of-Life Care during a Pandemic.

Olusegun Apoeso1, Caitlyn Kuwata1, Suzanne L Goldhirsch1, Natasha Piracha1, Amy Reyes-Arnaldy1, Jose De Leon1, Emily Chai1.   

Abstract

Background: Palliative care seeks to support the physical, psycho-social and spiritual needs of patients and families who are facing life threatening diseases. Advantages of establishing a palliative care unit, or alternatively co-locating patients, include promoting optimal physical and psychological symptom management; increased family satisfaction; and facilitating resource allocation. Objective: To design a stand-alone hospital unit to provide end of life care during a pandemic. Setting: Mount Sinai Hospital (MSH), a 1,144 bed tertiary- and quaternary-care teaching facility and Brookdale Department of Geriatrics and Palliative Medicine of the Icahn School of Medicine at Mt Sinai. Method: Tracking key indicators signaling the need for conversion to a COVID-19 unit, and identifying factors to facilitate a successful conversion. Result/Implementation: Using previously identified key focused action categories as framework, we describe our successful palliative care unit (PCU) conversion into a COVID-19 care unit.
Conclusion: We believe that these operational insights gained from transforming our unit during COVID-19 will be helpful to other programs and institutions during a pandemic, or public health emergencies.

Entities:  

Keywords:  colocation of patients in a pandemic; end-of-life care in a pandemic; palliative care unit in a pandemic

Mesh:

Year:  2020        PMID: 32936044     DOI: 10.1089/jpm.2020.0502

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  1 in total

Review 1.  [Strategies, guidelines and recommendations for coping with the COVID-19 pandemic in palliative and hospice care facilities. Results of a scoping review].

Authors:  Diana Wahidie; Kübra Altinok; Yüce Yılmaz-Aslan; Patrick Brzoska
Journal:  Z Gerontol Geriatr       Date:  2022-01-21       Impact factor: 1.281

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.